Respiratory Distress Syndrome
📧 Sign up to get email alerts when something new happens for Respiratory Distress Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2021-04-23Clinical Trial Update: Effects of L-Carnitine Supplementation on Respiratory Distress Syndrome [Phase 4]
A Phase 4 trial evaluating L-Carnitine supplementation for respiratory distress syndrome in premature birth was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: SILtuximab in Viral ARds (SILVAR) Study [Phase 3]
Phase 3 trial of SILtuximab in viral ARDS (SILVAR) was terminated.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Medium vs Low Oxygen Threshold for the Surfactant Administration [Phase 4]
Phase 4 clinical trial evaluating medium versus low oxygen thresholds for surfactant administration in respiratory distress syndrome.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) [Phase 3]
Phase 3 trial evaluating Dornase Alfa for ARDS in patients with SARS-CoV-2 completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial [Phase 3]
A completed Phase 3 randomized controlled trial evaluating the efficacy and safety of Remdesivir and Tociluzumab for severe COVID-19 and rel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-03-12Clinical Trial Update: Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19) [Phase 3]
Phase 3 trial evaluating tPA for atypical ARDS in COVID-19 has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE) [Phase 2]
Phase 2 clinical trial update for AMY-101, a C3 inhibitor, in patients with ARDS due to severe COVID-19 (SARS-CoV-2 infection).
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19 [Phase 2]
Phase 2 trial update investigating whether trimetazidine can prevent acute myocardial injury in patients hospitalized with COVID-19.
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19 [Phase 2]
A Phase 2 pilot study evaluating antithrombin as a preventive therapy for acute respiratory distress syndrome in hospitalized COVID-19 patie…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 [Phase 2]
Phase 2 trial update for Curosurf in adult acute respiratory distress syndrome due to COVID-19.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 [Phase 4]
Phase 4 trial update on dexamethasone for ARDS caused by COVID-19; the study status shows TERMINATED.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating autologous activated platelet-rich plasma therapy for managing cytokine storms in severe COVID-19 pati…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Empirical Steroids and/or Antifungals in Immunocompromised Patients With Acute Respiratory Failure From Undetermined Etiology: a Multicenter Double-blind Randomized Controlled Trial [Phase 3]
A Phase 3 randomized, double-blind trial evaluating empirical steroids and/or antifungals in immunocompromised patients with acute respirato…
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency [Phase 2]
Phase 2 clinical trial update evaluating senicapoc in COVID-19 patients with severe respiratory insufficiency (ARDS).
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: Effects of Sevoflurane on Extravascular Lung Water and Pulmonary Vascular Permeability in Patients With ARDS [Phase 3]
Phase 3 trial evaluating sevoflurane effects on extravascular lung water and pulmonary vascular permeability in patients with ARDS.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia [Phase 3]
A Phase 3 trial comparing tocilizumab with DefeROxamine plus standard treatments in ICU-admitted COVID-19 patients in Tunisia; efficacy and …
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 [Phase 3]
Phase 3 trial comparing dexamethasone versus methylprednisolone for ARDS caused by COVID-19. Status not specified in the source.
-
CLINICAL_TRIALS trial_result · 2020-08-18Clinical Trial Update: Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome [Phase 2, Phase 3]
A clinical trial update on convalescent plasma therapy for COVID-19 patients with acute respiratory distress syndrome across Phase 2 and Pha…
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III [Phase 3]
Phase 3 trial assessing dexamethasone for COVID-19-associated ARDS was terminated. The study evaluated dexamethasone treatment in patients w…
-
CLINICAL_TRIALS trial_result · 2020-06-24Clinical Trial Update: Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial [Phase 4]
A Phase 4 clinical trial update evaluating anticoagulation in patients with COVID-19–related ARDS.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Effects of Non-invasive Ventilation With Helium-oxygen Mixture in Premature Infants With Respiratory Distress Syndrome [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating non-invasive ventilation using helium-oxygen mixtures in premature infants with respiratory distress s…
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
A completed clinical trial investigating methylprednisolone for patients with severe acute respiratory syndrome due to coronavirus infection…
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 [Phase 2]
Phase 2 clinical trial update for mesenchymal stem cells in acute respiratory distress syndrome associated with COVID-19 is in progress with…
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19) [Phase 2]
Phase 2 trial update for mavrilimumab in severe COVID-19 pneumonia with hyperinflammation (COMBAT-19) is ongoing; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the efficacy of different antiviral drugs in patients with SARS-CoV infection and COVID-19, with unclear curren…